Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Zoono Group Limited ( (AU:ZNO) ) is now available.
Zoono Group Limited reported a 19.1% increase in revenue to NZ$1,250,133 for the year ending June 2025, while significantly reducing its net loss by 59% to NZ$3,766,769. Despite the improved financial performance, the company decided not to pay a dividend for the year, indicating a cautious approach as it continues to stabilize its operations and strengthen its market position.
More about Zoono Group Limited
Zoono Group Limited operates in the biotechnology industry, focusing on the development and distribution of antimicrobial solutions. Their primary products are aimed at providing long-lasting protection against germs and pathogens, with a market focus on health and hygiene sectors.
Average Trading Volume: 343,453
Technical Sentiment Signal: Sell
Current Market Cap: A$12.47M
Find detailed analytics on ZNO stock on TipRanks’ Stock Analysis page.